Current Molecular Medicine
Title:Editorial [Hot Topic: Heat Shock Proteins in Cancer]
Volume: 12 Issue: 9
Author(s): Andre-Patrick Arrigo
Affiliation:
Export Options
About this article
Cite this article as:
Arrigo Andre-Patrick, Editorial [Hot Topic: Heat Shock Proteins in Cancer], Current Molecular Medicine 2012; 12 (9) . https://dx.doi.org/10.2174/156652412803306738
DOI https://dx.doi.org/10.2174/156652412803306738 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Too Much of a Good Thing: Suicide Prevention Promotes Chemoresistance in Ovarian Carcinoma
Current Cancer Drug Targets Systematic Analysis of Large Screening Sets in Drug Discovery
Current Drug Discovery Technologies The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Therapeutic Approaches of Leptin in Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Longevity Depends on a Balance Between Proinflammatory and Anti-Inflammatory Factors: Use of Tcms and Natural Products
Current Drug Discovery Technologies Statins and Type 2 Diabetes Mellitus: An Update After 1 Year
Current Pharmaceutical Design The Role of Heat Shock Protein -90 (HSP-90) in Inflammatory Disorders
Current Chemical Biology Receptor Tyrosine Kinases as Therapeutic Targets the Model of the MET Oncogene
Current Drug Targets Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Current Cancer Therapy Reviews Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
CNS & Neurological Disorders - Drug Targets Gastrointestinal Polyposis Syndromes
Current Molecular Medicine Synergic Photosensitizers: A New Trend in Photodynamic Therapy
Current Organic Chemistry Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment
Recent Patents on Anti-Cancer Drug Discovery Cyclooxygenases Regulation by Estradiol on Endothelium
Current Pharmaceutical Design Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Current Signal Transduction Therapy SNAP-tag based Agents for Preclinical In Vitro Imaging in Malignant Diseases
Current Pharmaceutical Design Bcl-2 Family Proteins Regulate Apoptosis and Epithelial to Mesenchymal Transition by Calcium Signals
Current Pharmaceutical Design Knowledge of Epigenetic Influence for Prostate Cancer Therapy
Current Cancer Drug Targets Editorial (Hot Topic: Targeted Therapies in the Treatment of Breast Cancer and Localized Sarcomas)
Current Medicinal Chemistry Foreword
Current Pharmaceutical Design